Safety Study of Vasopressin V2 Receptor Antagonist on Patients With Severe Chronic Heart Failure (AQUAVIT).

This study has been completed.

Study NCT00032747 Information provided by Sanofi-Aventis

First Received: March 29, 2002 Last Updated: June 16, 2008 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	February 2003
Estimated Primary Completion Date:	No date given